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Abnormal FDG Uptake in the Pericardial Adipose 
Tissue Mimicking Malignancy 
Sumina R. Goel, M.D., Munir Ghesani, M.D., E. Gordon DePuey, M.D., 
and Sugganth Daniel, M.D. 
Focal mediastinal F-18 FDG uptake may be from potential adenopathy requiring biopsy confir-
mation or benign active brown adipose tissue to be left untouched. Knowledge of this potential 
pitfall and precise localization with fusion PET/CT are important in preventing misinterpretation 
as malignancy. Our case report is important in the aspect that CT was not able to confirm the up-
take as benign finding, which led to invasive biopsy and biopsy confirmed it to be a benign brown 
adipose tissue.
A 57-year-old woman was recently diagnosed with 
lung cancer. As part of the evaluation, PET/CT scan of 
the whole body was performed. It revealed high-grade 
uptake at the site of primary malignancy in the right 
lower lobe with a mean SUV of 7.8 (Fig. 1) and a 10 
Case Report
Figure 1. 57-year-old woman with lung cancer. The PET/
CT image showing hypermetabolic activity in the primary 
malignancy of the right lung (Arrows) and hypermetabolic 
activity in the pericardial region (Arrowhead), suspicion of 
metastatic lymphadenopathy was raised.
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Figure 2. The 3D views of the coronal, sagittal and transaxial views of the CT, PET and fused PET/CT showing the pericardial 
uptake.
The focal mediastinal uptake in the FDG/PET 
imaging has been described, which on CT confirm 
the activity to be either in the brown adipose tissue or 
in the lymph node (1-4). PET with CT can usually 
identify suspicious lymph nodes that require biopsy 
Discussion
by 7 mm ipsilateral precarinal lymph node with mean 
SUV of 2.4 (not shown). In addition, it revealed a 
hyperactive metabolic nodular density with mean SUV 
of 2.4, localized anterior and to the left of the main 
pulmonary artery (Fig. 1-arrow). The CT portion of 
the PET/CT described it as soft tissue nodular density 
of about 11*7 cm in size and 40 house field units. The 
possibility of additional focus of metastatic lymphade-
nopathy was raised. The prior dedicated chest CT 2 
weeks before PET/CT staging described it as soft tissue 
density, of unknown significance. The 3D PET, CT 
and PET/CT fusion imaging was not more helpful to 
further characterize the lesion in terms of its benign or 
malignant nature (Figure 2). The biopsy was performed 
shortly after the PET/CT scan and 3 months after the 
biopsy of primary lesion. The gross description of the 
lesion was described as yellow fatty tissue of 1.5 by 1.4 
by 1.0 cm in size and final diagnosis was “pericardial 
adipose tissue with no evidence of malignancy” (Fig. 3). 
The biopsy of the primary lesion of the lung 3 months 
before showed a large cell (non-small cell) type cancer 
(Fig. 4). The CD56 (Fig. 5) and synaptophysin antibody 
markers (Fig. 6) showed the primary lung cancer to be 
of neuroendocrine differentiation. Patient underwent 
radiation and chemotherapy treatment. Subsequent 
follow-up with PET/CT 6 months later (Fig. 7) showed 
marked improvement in the primary lesion showing 
photopenia with minimal rim of hypermetabolic activity 
and no new lesions. The contralateral pericardial soft 
tissue nodular density was unchanged in appearance and 
showed a mild decrease in SUV from 2.4 to 2.0. 
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Figure 4. Histopathologic examination of primary malig-
nancy reveals large cell type lung cancer. 
Figure 5. The CD56 antibody showed the primary malig-
nancy to be of neuroendocrine origin. 
Figure 3. Histopathology of pericardial tissue shows it to be 
adipose tissue. 
Figure 6. Synaptophysin stain showed the primary malig-
nancy to be of neuroendocrine origin. 
(5). Hypermetabolic brown fat can be localized to the 
mediastinum and manifests as focal increased FDG 
uptake. Knowledge of this potential pitfall and precise 
localization with fusion PET/CT are important in 
preventing misinterpretation as malignancy (2). In most 
of the cases, the location, symmetry and shape of the 
FDG uptake can differentiate benign tissue from malig-
nancy. Typical supraclavicular adipose tissue is bilateral, 
curvilinear, symmetric and elongated; the appearance 
is rarely confused with malignancy. The mediastinal 
adipose tissue uptake can be seen in the following areas: 
azygous vein, brachiocephalic artery, interatrial septum, 
hemiazygous vein, azygoesophageal recess, pericardial, 
prevascular and paratracheal adipose tissue. The benign 
FDG uptake in mediastinal adipose tissue is usually 
focal and spherical (2). Positive mediastinal FDG uptake 
is considered abnormal, when it is substantially larger 
than mediastinal blood pool activity. However, the me-
diastinal F-18 FDG uptake is less specific and could be 
seen in many different disease entities, which includes 
infection, inflammation, breathing motion artifact and 
atrial appendage radiotracer. These entities may also 
simulate mediastinal primary or secondary malignancy. 
Due to the imperfect specificity of positron emission 
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Figure 7. ix month follow-up PET/CT showing marked improvement in the primary lesion (arrow) and non-significant de-
crease in soft tissue pericardial density, when compared to the prior PET scan. 
tomography, biopsies recommended for all PET positive 
mediastinal lymph nodes in order to confirm or rule out 
metastasis (6). Though, there are no SUV cut offs for 
malignancy and furthermore there is a lot of SUV vari-
ability based on different acquisitions and timing of scan 
relative to dose, the SUV ratio can distinguish benign 
vs. malignant focus. The ratio of the maximum SUV 
of the mediastinal (N2) lymph node to the maximum 
SUV of the primary tumor in patients with non small-
cell lung cancer predicts mediastinal nodal pathology. 
When the ratio is 0.56 or greater, there is a 94% chance 
that the node is malignant. In our case, the ratio was 
0.30(again, the ratio may take into account the different 
techniques used at different centers (7)). In non-small 
cell lung cancer, PET may reduce the necessity for 
mediastinoscopy when the primary lesion standardized 
uptake value is less than 2.5 and the mediastinum is 
PET negative (8).
In the case present, we were unable to distinguish 
normal brown fat from the metastatic lymph node on 
CT. As it is highly unusual to have contralateral peri-
cardial mediastinal node activity without intervening 
ipsilateral nodal activity, the involvement of the ipsi-
lateral precarinal lymph node raised the suspicion of ma-
lignancy in the contralateral pericardial hypermetabolic 
tissue. The SUV ratio of the suspected lymph node to 
the primary malignancy may have potentially suggested 
benign nature of the lymph node. Further evaluation 
with biopsy confirmed it as brown fat. 
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